Achieve Life Sciences (ACHV) vs Apnimed (APMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Apnimed is the larger company by market cap ($748.3 million vs $742.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACHV | APMD |
|---|---|---|
| Share price | $7.20 | $17.98 |
| Market cap | $742.34M | $748.31M |
| 1-day change | -0.55% | -0.36% |
| YTD return | +45.67% | — |
| 1-year return | +118.07% | — |
| 5-year return | -10.06% | — |
| P/E ratio (TTM) | — | 2.49 |
| EPS (TTM) | $-1.69 | $7.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.64 | $35.29 |
| 52-week low | $2.62 | $16.12 |
| Distance from 52-week high | -16.67% | -49.06% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +96.53% | +180.00% |
| Average volume | 1.44M | 556.65K |
| Shares outstanding | 103.10M | 41.63M |
| Employees | 28 | 81 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Achieve Life Sciences
ACHV stock →Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 28 employees
About Apnimed
APMD stock →Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets.
Health Care · Biotechnology: Pharmaceutical Preparations · 81 employees
ACHV vs APMD FAQ
Which is bigger, Achieve Life Sciences or Apnimed?
Apnimed (APMD) is larger, with a market capitalization of $748.31M compared with $742.34M for Achieve Life Sciences (ACHV).
Are Achieve Life Sciences and Apnimed in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: In Vitro & In Vivo Diagnostic Substances for Achieve Life Sciences and Biotechnology: Pharmaceutical Preparations for Apnimed.